MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Spyre Therapeutics, Inc. Common Stock

SYRE

#1464
Spyre Therapeutics, Inc. Common Stock
43.0100
+1.70%
Sector:
Base:
Profit Currency:
Daily Range
43.0100
43.0100
Year Range
21.1500
45.7400
Daily Change
+1.70%
Monthly Change
+28.58%
6 month change
+79.88%
Year Change
+79.88%
Previous Close
42.2900
Open
43.0100
Bid
Ask
Low
43.0100
High
43.0100
Volume
115
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. SYRE
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

News

TipRanks TipRanks
SYRE NVDA HOOD
2026.02.24
3 ‘Strong Buy’ Stocks to Buy in Today’s Volatile Market, 2/23/2026, According to Top Analysts - TipRanks.com
Investing Investing
SYRE
2026.02.20
Spyre Therapeutics stock hits 52-week high at 42.93 USD
Investing Investing
SYRE
2026.02.13
Spyre Therapeutics stock hits 52-week high at 35.82 USD
Investing Investing
GSK LLY ROG GMAB TEVA
2026.01.26
Drugmakers turn to AI to speed trials, regulatory submissions
Investing Investing
SYRE
2026.01.12
Spyre Therapeutics accelerates clinical trial timeline for IBD treatments
Investing Investing
SYRE
2026.01.07
Turtle Cameron, CEO of Spyre Therapeutics, sells $460k in shares
Seeking Alpha Seeking Alpha
SYRE
2026.01.01
Spyre Therapeutics Stock: Validated Targets, Optimized Delivery (NASDAQ:SYRE)
Investing Investing
SYRE
2025.12.17
Mizuho initiates Spyre Therapeutics stock with Outperform rating
Investing Investing
SYRE
2025.12.11
Spyre Therapeutics stock hits 52-week high at 35.0 USD
Investing Investing
SYRE
2025.12.04
Spyre Therapeutics CEO Turtle Cameron sells $435k in stock
Investing Investing
SYRE
2025.12.03
Spyre Therapeutics stock reaches 52-week high at 30.56 USD
Benzinga Benzinga
NMRA ODFL TOST CVX SYRE
2025.12.01
This Chevron Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Chevron (NYSE:CVX), Neumora Therapeutics (NASDAQ:NMRA)

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd